Connect with us

Stock News

Ascendis Pharma’s stock surges after FDA approval for first and only treatment for rare disease

Published

on


The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.

Continue Reading

Stock News

America is doing better than the media or our politicians tell us. Here’s proof.

Published

on


Washington, D.C. doesn’t work. You know what does? America itself.

Continue Reading

Stock News

Trump tariffs: These states would be hit hardest by proposed import taxes

Published

on


Donald Trump’s most controversial economic-policy proposal is to institute a 10% tariff on all products and materials imported from abroad, a move that would upend decades of U.S. trade policy and potentially spark tit-for-tat trade wars with American allies and adversaries alike.

Continue Reading

Stock News

Google gets new head of search and ad business as part of AI-focused reshuffling

Published

on


Google is getting a new leader for its core business, which includes search, ads and commerce, as the tech giant restructures itself for the AI era.

Continue Reading

Trending